top of page
17 January 2024
Horizon Capital invests in Viseven Group
Other News
Congratulations to our member Horizon Capital with an investment in Viseven Group, one of the world's leading marketing technology companies.
Viseven serves more than 50 clients in the pharmaceutical and life sciences industries, as well as clients from 20 of the world's leading companies, including Abbott, AbbVie, Amgen, Bayer, Biogen, Ipsen, Lilly, Novo Nordisk, Servier Laboratories and others. The company demonstrates high performance, profitability, and a stable level of growth, as evidenced by the more than threefold increase in revenues since 2019.
More details can be found at this link. Our best wishes for success to the teams!

bottom of page